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ABSTRACT
Nearly all bacteria exhibit a type of pheno-
typic growth described as persistence that is
thought to underlie antibiotic tolerance and recal-
citrant chronic infections. The chromosomally en-
coded high-persistence (Hip) toxin–antitoxin pro-
teins HipASO and HipBSO from Shewanella oneiden-
sis, a proteobacterium with unusual respiratory ca-
pacities, constitute a type II toxin–antitoxin protein
module. Here we show that phosphorylated HipASO
can engage in an unexpected ternary complex with
HipBSO and double-stranded operator DNA that is
distinct from the prototypical counterpart complex
from Escherichia coli. The structure of HipBSO in
complex with operator DNA reveals a flexible C-
terminus that is sequestered by HipASO in the ternary
complex, indicative of its role in binding HipASO to
abolish its function in persistence. The structure
of HipASO in complex with a non-hydrolyzable ATP
analogue shows that HipASO autophosphorylation is
coupled to an unusual conformational change of its
phosphorylation loop. However, HipASO is unable to
phosphorylate the translation factor Elongation fac-
tor Tu, contrary to previous reports, but in agree-
ment with more recent findings. Our studies suggest
that the phosphorylation state of HipA is an impor-
tant factor in persistence and that the structural and
mechanistic diversity of HipAB modules as regula-
tory factors in bacterial persistence is broader than
previously thought.
INTRODUCTION
To cope with unpredictable environmental fluctuations,
bacteria resorted to population diversity as a risk-spreading
strategy. By creating a phenotypic or genetically heteroge-
neous population, bacteria essentially increase the proba-
bility that at least a subpopulation is well adapted to the
actual environment (1–3). A striking example of such phe-
notypic diversity is the emergence of a small subpopulation
of persister cells that are able to survive against an antibi-
otic challenge by entering a dormant state with an increased
tolerance against a wide variety of stresses (4). Recently, a
strong correlation between persister cells and the multidrug
tolerance (MDT) of biofilms has been shown. Thus, gaining
insights into bacterial persistence could create avenues for
the development of new antimicrobial drugs and for com-
bating chronic infections (5,6). While bacterial persistence
was discovered almost 70 years ago, its understanding at
the molecular level is a relatively recent development and
has coincided with the discovery of the hipA gene in Es-
cherichia coli (7–9). The products of hipA and its upstream
linked gene hipB form a toxin–antitoxin module, which to-
gether are recognized as a major factor involved in persis-
tence (10,11). The toxin HipA is a protein kinase and its ac-
tivity is essential for growth arrest and MDT in E. coliK12
(12). A first functional annotation of HipA by Schumacher
et al. linkedHipA to phosphorylation of the elongation fac-
tor Tu (EF-Tu) resulting in inhibition of protein biosyn-
thesis. However, more recent studies have demonstrated
that not EF-Tu, but glutamyl-tRNA synthetase (GltX) is
the phosphorylation target of HipA (13,14). Furthermore,
HipA has been shown to trigger growth arrest by control-
ling RelA-mediated biosynthesis of the alarmone (p)ppGpp
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(15,16). HipA activity is inhibited upon binding to HipB
and through sequestration to the nucleoid, as both HipB
and the HipBA complex bind to their corresponding oper-
ators, thereby leading to suppression of their own gene tran-
scription (14). However, the molecular mechanisms behind
such temporary growth arrest remain unclear and neither is
it known what exactly triggers the escape from dormancy.
We previously demonstrated that interruption of the
SO0706 gene in Shewanella oneidensis MR-1 (SO) resulted
in a 50% decrease of biofilm formation (17). This gene en-
codes a protein sharing 28% sequence identity with E. coli
HipA. S. oneidensis MR-1 is a respiratory diverse model
bacterium that attracted interest due to its role in biogeo-
chemistry, its potential for bioremediation of heavy metals
and aromatic compounds as well as for its use in micro-
bial fuel cells (18–20). Many of these applications rely on
the potential of the organism to form biofilms on inorganic
surfaces. Molecular studies on the mechanisms of biofilm
formation by S. oneidensis established a role for a type IV
pilus system, the presence of extracellular DNA and the
mxdABCD gene cluster, encoding a polysaccharide biogen-
esis system (21). A microarray analysis of the early stage
of biofilm formation revealed the involvement of different
metabolic processes and cyclic di-GMP dependent path-
ways, which was recently confirmed by molecular charac-
terization of PdeB, a c-di-GMP phosphodiesterase (22,23).
The sequencing of the S. oneidensisMR-1 genome inspired
efforts to gain insight into its regulatory and metabolic net-
works and their relationship to physiology (24,20).
Given the strong correlation between biofilm formation
and persistence in bacteria, as well as the potential in-
volvement of SO0706 in this process, we sought to inves-
tigate structure–function relationships of the SO0706 prod-
uct. Here, we provide structural insights into the unexpected
participation of the phosphorylatedHipA toxin in a ternary
assembly with the antitoxin HipB and their operator DNA.
We show that phosphorylation of HipA at a serine residue
buried deeply in the structure is coupled to conformational
ejection of the phosphorylation loop (pLoop). However,
our direct observation of phosphorylated HipA in a ternary
complex indicates that HipB could rescue growth arrest
by directly targeting the phosphorylated HipA population.
Furthermore, the C-terminus of HipB undergoes dramatic
conformational changes between the unbound form and
when in complex with HipA and operator DNA, indicating
the possible regulatory role of such interaction via preven-
tion of proteolysis. Furthermore, we find that S. oneidensis
MR-1 HipA is neither able to bind to nor can phosphory-
late EF-Tu, which is in agreement with recent findings for
the E. coli counterpart. Together, our studies provide new
insights into the possible involvement of HipA and HipB in
bacterial persistence and open new experimental possibili-
ties for interrogating the role of both proteins in the persis-
tence regulatory mechanisms.
MATERIALS AND METHODS
Expression and purification of recombinant proteins and com-
plexes thereof
Expression constructs for S. oneidensis MR-1 HipAso
(SO0706) and HipBso (SO0705) were established based on
primers MR01, MR02 for HipAso and MR03, MR04 for
HipBso (Supplementary Table S1), and were cloned into the
pET15b expression vector (Merck Millipore). The D306Q
mutant of HipAso was generated via overlap polymerase
chain reaction (PCR) using the flanking primer MR01
and internal primer MR06 in one reaction and the flank-
ing primer MR02 and internal primer MR05 in another
reaction. The PCR products were gel purified and used
in a final overlap PCR round using the flanking primers
MR01 and MR02. An expression construct for S. onei-
densis MR-1 EF-Tu was cloned into a pET11b vector
(Merck Millipore) containing a C-terminal 6xHis-tag se-
quence with primers MR07 and MR08 from S. oneiden-
sis MR-1 genomic DNA (Supplementary Table S1) and
into the pGEX-4T-2 vector (GE Healthcare). S. oneiden-
sis MR-1 HipAso and HipBso were expressed in E. coli
BL21 DE3 and EF-Tuso in E. coli C43. Bacterial cultures
were induced for 1 h (HipAso) or 4 h (HipBso and EF-
Tuso) with 1 mM isopropyl -D-1-thiogalactopyranoside
(Duchefa Biochemie) after growth to an OD600nm of 0.6–
0.7 in Lysogeny Broth (LB) medium supplied with Car-
benicillin (100 g/ml) at 37oC. The cells were harvested
by centrifugation at 7000 × g for 10 min at 4◦C. After re-
suspending the cell pellets in 25 mM Na2HPO4 pH 7.5,
500 mM NaCl buffer with ethylenediaminetetraaceticacid-
free protease inhibitor cocktail (Roche), the cellular sus-
pension was sonicated and the soluble fraction was clari-
fied by centrifugation at 75 000 × g for 30 min. The clari-
fied lysate was loaded onto a Ni-NTA column (Qiagen) and
pre-equilibrated with buffer A (25 mM Na2HPO4 pH 7.5,
500 mM NaCl, 10 mM imidazole), washed with buffer B
(25 mM Na2HPO4 pH 7.5, 500 mM NaCl, 50 mM imida-
zole) and eluted with gradient buffer C (25 mM Na2HPO4
pH 7.5, 500 mM NaCl, 500 mM imidazole). The recombi-
nant proteins were concentrated and subsequently further
purified by size exclusion chromatography (SEC) on a Prep-
Grade Hiload 16/60 Superdex200 column (GE Health-
care) equilibrated with buffer (10 mM HEPES pH 7.5, 300
mM NaCl and 5% glycerol). EF-Tuso was overexpressed
and purified as described in (25), with modification of the
buffer (300 mM NaCl, 25 mM Na2HPO4 pH 7.5, 15 M
GDP, 5 mM MgCl2). The N-terminal 6× His-tag of HipB
was cleaved with biotinylated thrombin (Novagen) during
overnight incubation and repurified by SEC. Pure fractions
were pooled and proteins were concentrated for further ex-
periments. To assemble the HipABso:DNA ternary com-
plex, purified HipAso and HipBso were mixed with double-
stranded operator DNA obtained by annealing two sin-
gle primers 5′-ATTAGGTGTACTTATCTACACTTTTT-
3′ and 5′-AAAAAGTGTAGATAAGTACACCTAAT-3′
(IDT). The HipABso–DNA complex was further purified
by size-exclusion chromatography.
Crystallographic studies ofHipABso:DNA complex,HipAso–
AMPPNP–Mg2+ and HipBso
All crystallization trial experiments were performed via
the vapor diffusion method using a Mosquito robot (TTP
LabTech). Crystals of HipAso in complex with Mg2+–
AMPPNP grew at 20◦C in two days from sitting-drops
formed by mixing 200 nl purified recombinant HipAso with
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2 mM AMPPNP (Sigma) and 10 mM MgCl2 with an
equal volume of reservoir solution (0.2 M sodium chlo-
ride, 0.1 M Na HEPES pH 7.0, 25% polyethylene glycol
4000). The crystallization droplets were equilibrated against
40 l reservoir solution. For X-ray data collection under
cryogenic conditions, the crystals were harvested from the
drop and frozen in a cryostream using crystallization condi-
tion supplemented with 20% glycerol as cryoprotection sol-
vent. Crystals of the HipAso–AMPPNP complex belonged
to space group P212121 with a = 60.70 A˚, b = 75.83 A˚, c =
110.32 A˚ and =  =  = 90◦ and diffracted to 1.83 A˚ res-
olution. Crystals of recombinant HipBso were grown using
purifiedHipBso after cleavage of theN-terminal 6×His-tag,
from 0.1 M Na HEPES pH 7.5, 10% v/v 2-propanol, 20%
PEG 4000. HipBso crystals diffracted to 1.85 A˚ and 2.35
A˚. and belonged to space group C2221 with a = 53.46 A˚, b
= 72.95 A˚, c = 86.91 A˚ and  =  =  = 90◦.
Crystals of recombinant HipABso in complex with op-
erator DNA were grown in the crystallization geometries
described above from reservoirs containing 0.2 M calcium
acetate hydrate pH 7.5, 20% polyethylene glycol 3350. For
cryoprotection, the HipABso:DNA crystals were first incu-
bated for several minutes in the crystallization condition
supplemented with 20% glycerol. We identified two crystal
forms that diffracted to 3.4 A˚ and 3.8 A˚ respectively. The
first crystal form diffracted to 3.4 A˚, and belonged to space
group P212121 with a = 57.8 A˚, b = 122.5 A˚, c = 189.9 A˚
and  =  =  = 90◦. The second crystal form in space
group P21 with a= 72.24 A˚, b= 57.33 A˚, c= 171.38 A˚ and
=  = 90◦, = 95.8◦ diffracted to 3.8 A˚ resolution. All X-
ray diffraction data were processed with XDS and the XIA2
routine (26,27).
The structure of HipAso–AMPPNP–Mg2+ was deter-
mined via the molecular replacement platform BALBES
(28), using the S. oneidensis MR-1 HipAso sequence and
the crystal structure of E. coli HipA (PDB: 3DNU) struc-
ture as input. The structure was extended to completion us-
ing Phenix.AutoMR and refined using Phenix.Refine (29).
The final HipA–AMPPNP–Mg2+ structure contains one
molecule of HipA per asymmetric unit cell including all 433
residues from HipA and 5 residues from the affinity purifi-
cation tag, 1 AMPPNP molecule, 2 Mg2+ ions, 1 Na+ ion
and 486 water molecules.
To determine the structure of HipBso, the S. oneiden-
sis MR-1 HipBso sequence and a subunit from the crys-
tal structure of dimeric E. coli HipB (PDB: 3DNV) were
used to create a truncated searchmodel lacking loop regions
and non-conserved side chains using CCP4 Chainsaw. The
structure was determined using molecular replacement pro-
tocols implemented in MOLREP and Phenix.Phaser and
was refined using Phenix.Refine (29,30). The final HipBso
structure contains one dimer HipBso in the crystal asym-
metric unit including residues 24–87 for one subunit and
residues 17–87 for the second subunit, 123 water molecules
in the dataset of 1.85 A˚ resolution and includes residues 17–
87 for both subunits, and 39 water molecules in the dataset
of 2.35 A˚ resolution.
The HipABso:DNA complex structure was determined
by molecular replacement protocols implemented in
Phenix.AutoMR using the HipA–AMPPNPmonomer and
the HipBso dimer as search models. The limited diffraction
quality of crystal forms 1 and 2 for the HipABso:DNA
complex necessitated the use of weak data at the diffraction
limit of the crystals as indicated by half-dataset Pearson
correlation coefficient (CC1/2) (31). Both the orthorhombic
and monoclinic crystals contain two monomers of HipAso,
one dimer of HipBso and double-stranded DNA in the
asymmetric unit cell. After initial rounds of refinement,
clear electron density could be observed for the DNA du-
plex that allowed modeling of the complete DNA sequence
in COOT (32). The final HipABso:DNA structure contains
two molecules of phosphorylated HipAso covering residues
7–433, one dimer of HipBso including residues 20–87 and
95–97, and one molecule of double-stranded DNA with 24
and 25 nucleotides in each strand.
Crystallographic coordinates and structure factors were
deposited to the Protein Data Bank with access codes
4PU3, 4PU4, 4PU5, 4PU7 and 4PU8.
Nano liquid chromatography mass spectrometry
Freshly purified HipAso and HipAso treated overnight in
vitro with 10 mM ATP, 20 mM MgCl2 were diluted 1:50
with 50 mM ammonium bicarbonate buffer. Sequencing-
grade trypsin (Sigma) was added in 1:50 ratio to the diluted
protein and digested overnight at 37◦C.One picomoleHipA
digestion from those two samples was applied for LCMS
analysis on a nanoACQUITY UPLC coupled to a Synapt
mass spectrometer used in the Q-TOF mode (Waters). A
nanoACQUITY UPLC@2G-V/M Trap column 108 m *
20mm 5  symmetry C18 (Waters) was used as the trap col-
umn at 15 l/min for 1 min. A nanoACQUITY UPLC 1.8
m HSS T3 75 m * 250 mm column (Waters) was used
as the separation column at 0.25 l/min with a gradient as
follows: 3% B to 40% B (0–30 min), 40% B to 85% B (30–31
min), 85% B (31–35 min), 85% B to 3% B (35–35.5 min), 3%
B until 65 min using 0.1 formic acid as buffer A and 100%
acetonitrile as buffer B. All the Nano LCMS data were pro-
cessed with the PLGS 2.5 software (Waters).
Isothermal titration calorimetry
Experiments were carried out on aVP-ITCMicroCalorime-
ter at 25◦C and data were analyzed using the origin ITC
analysis software package (MicroCal). Purified HipA (WT
or D306Q), HipB and DNA were matched into the buffer
containing 25 mM Na2HPO4, 300 mM NaCl and 5% glyc-
erol at pH 7.5. The concentrations of HipAso, HipBso and
DNA were measured by a Nanodrop spectrophotometer
using an extinction coefficient generated from ProtParam
(Uniprot Knowledgebase). All samples were degassed ex-
tensively prior to the experiments. An initial injection of
2 l was followed by 10 l injection spaced 250 s or 350
s apart. The raw data were corrected and fitted to the one
binding site model, and apparent molar reaction enthalpy
(H), apparent entropy (S), dissociation constant (KD)
and stoichiometry of binding (N) were generated.
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Small angle X-ray scattering
Small angle X-ray scattering (SAXS) measurements of
HipBso, HipBso:DNA and HipABso:DNA were carried out
at Beamline SWING in SOLEIL (SOLEIL, Paris, France)
with online HPLC separation (Shodex) in 25 mM HEPES
pH 7.5, 300 mM NaCl and 5% glycerol buffer. Buffer sub-
traction and extrapolation were performed with the pro-
gram FOXTROT or PRIMUS. The Guinier region was
evaluated by PRIMUS using the Guinier approximation.
The Porod volume was evaluated using PRIMUS; the ra-
dius of gyration Rg, forward scattering I0, maximum parti-
cle dimension Dmax and the distance distribution function
P(r) were evaluated using GNOM. Theoretical scattering
patterns from available structures and generatedmodels, to-
gether with their respective discrepancy to the experimental
data, were calculated using CRYSOL from ATSAS pack-
age (33,34). The molecular weight estimation was generated
with the protocol described before (35). Modeling of the N-
and C-termini of HipBso and HipBso:DNA was performed
using crystal structures of HipBso from the 1.85 A˚ dataset
of HipBso and HipBso:DNA from the 3.4 A˚ dataset of the
HipABso:DNA complex. Five CORAL jobs were run for
both HipB and HipBso:DNA using different seeds for each
run, implying no symmetry (P1) and extending the N- and
C-termini with 25 N-terminal and 10 C-terminal dummy
residues for HipBso alone and in complex with DNA.
Bacterial growth experiments
Markerless in-frame deletion mutants in S. oneidensis
were constructed essentially as previously reported using
the suicide vector pNPTS138-R6KT (36,23). The primers
used to generate the required N- and C-terminal frag-
ments of the target regions (MR09/10/11/12 for hipBso,
MR13/14/15/16 for hipAso, MR09/10/15/17 for hipBAso)
are listed in Supplementary Table S1. The mutant alleles
were generated by overlap PCR using appropriate primer
combinations. Double cross-over mutants were selected as
described, and were validated by colony PCR and sequenc-
ing of the target regions. Construction of the hipB dele-
tion mutant failed, probably due to the toxicity of HipA.
To obtain the overexpression vectors, hipAso, hipBso and
hipABso were amplified from genomic DNA of S. oneiden-
sisMR-1 (primers MR18 andMR21 for hipAso, MR19 and
MR20 for hipBso and MR19, MR21 for hipABso) (Supple-
mentaryTable S1). The obtained PCRproducts were cloned
into the pBAD202/D-TOPO vector (Invitrogen). Subse-
quently, the thioredoxin sequence was removed by digestion
with NcoI, gel purification and re-ligation, producing the
pBADHipAso, pBADHipBso and pBADHipABso vectors,
respectively. Plasmid DNA was introduced into S. oneiden-
sis MR-1 cells by electroporation using a 2.5 kV pulse. All
mutants were confirmed by colony PCR using the appro-
priate primers. S. oneidensis strains were routinely grown on
LB agar plates or shaking (200 rpm) in LB medium at 28◦C
(media supplemented appropriately with carbenicillin (Cb)
100 g/ml or kanamycin (Km) 25 g/ml). For the growth
curves, overnight grown precultures were diluted 1:20 to
1:30 to an optical density at 600 nm (OD600nm) of ∼0.3.
Aerobic growth was monitored directly, without the need to
transfer culture samples into regular cuvettes, using a Shi-
madzu 1240 Mini Single-Beam UV-Vis spectrophotometer.
Each growth curve was derived from three independent ex-
periments for which the mean (±SEM) is plotted.
Radioactive kinase assay to probe HipAso activity
A standard radioactive kinase assay was performed in 11
l of reaction buffer (25 mM HEPES pH 7.5, 150 mM
NaCl, 25mM -glycerophosphate, 1mMNa3VO4, 100M
ATP and 100 M MgCl2) in the presence of 10 Ci of [ -
32P]ATP and the purified HipAso and EF-Tuso. The reac-
tion was allowed to incubate for 15 min at room tempera-
ture and quenched by the addition of 1/5 volume of sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) loading buffer. The 32P labeled proteins were sep-
arated by SDS-PAGE, followed by autoradiography of the
gels. As a negative control, a reaction without 32P and a re-
action with bovine serum albumin were included.
RT-PCR experiments
Total RNA was isolated from a 0.5 ml late-exponential
phase culture (OD600nm = 0.9) of WT S. oneidensis MR-1
using the RNeasy Plus Mini kit in combination with the
RNAprotect Bacteria Reagent (Qiagen) (yield: 33 g total
RNA). One microgram of total RNA sample was treated
with RNase-free DNase I and Protector RNase Inhibitor
(Roche). First strand cDNA was synthesized using random
hexamer primers and the Transcriptor First Strand cDNA
Synthesis Kit (Roche). Target transcripts were PCR am-
plified using HotGoldStar polymerase (Eurogentech) (100
ng DNA template; 4 M primers). PCR products were re-
solved on an agarose gel.
RESULTS
HipAso and HipBso constitute a toxin–antitoxin module with
an atypical operator DNA
Transposon mutagenesis of SO0706 led to a strong reduc-
tion of biofilm formation in S. oneidensis MR-1 (17). Se-
quence analysis revealed that the protein product of SO0706
(HipAso) shows clear homology to E. coli HipA with 28%
sequence identity (Supplementary Figure S1). The protein
product of the adjacent gene, SO0705 (HipBso), is anno-
tated as a toxin–antitoxin antidote transcriptional repressor
(20). Togetherwith the rather low sequence identity between
the S. oneidensis and E. coli HipA–HipB sequences, there
are also striking differences in the operon structure, which
may reflect the functional diversity of such toxin–antitoxin
systems. For instance, the SO0705 and SO0706 genes are
separated by 3 bp instead of overlapping by 1 bp as seen
in the hipAB operon structure in E. coli. Furthermore, a
palindromic operator sequence GTGTA(N)6TACAC is re-
peated four times upstream of the hipABso gene. We note
that the random nucleotide sequence within the operator
is 2 bp shorter than in the E. coli HipAB system. Interest-
ingly, the fourth operator is located inside the HipBso open
reading frame and the spacing between the four operators
is different. While in S. oneidensis the operators are equally
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separated by 34 bp, in E. coli they are separated by 10, 21
and 10 bp, respectively (Supplementary Figure S2a).
To investigate the function ofHipAso andHipBso we used
S. oneidensis MR-1 cDNA to isolate the genes for HipBso,
HipAso, HipABso and its operatorDNA. By employingRT-
PCR on total RNA using primer pairs designed to span
the entire region of HipBso and HipAso, we were able to
show that the two genes are transcriptionally coupled (Sup-
plementary Figure S2b). We established complementation
and overexpression mutants to study the HipABso physio-
logical function and its role in persistence. To this end, we
constructed a series of vectors based on the pBAD vector
which was previously shown to allow well-controlled ex-
pression to study the toxic effects of HipA (15). Overexpres-
sion ofHipAso inS. oneidensisMR-1 causes a temporary in-
hibition of growth in both the wild type and the hipABso
strain (Supplementary Figure S2c), an effect that is tem-
pered when also HipBso is overexpressed. However, when
HipAso was overexpressed in the hipABso strain growth
inhibition was acute, consistent with similar observations in
E. coli (10). This strongly suggests that mild overexpression
of HipAso only causes a temporary inhibition but not ter-
mination of growth (37). Surprisingly, overexpression of the
antitoxin HipBso has the same inhibitory effect on growth
as expression of toxin HipAso. This could be explained by
possible cross talk of HipB with other systems involved in
transcriptional repression by analogy to recent findings in
E. coli whereby HipB was shown to regulate multiple pro-
moter sequences besides the hipAB module (38).
To enable studies toward obtaining structural and mech-
anistic insights into the role of HipAso and HipBso in
persistence, we overexpressed and purified recombinant
HipAso and HipBso. Elution profiles during SEC showed
that HipAso could be isolated as a monomer with an ap-
parent molecular weight of 50 kDa, while HipBso could be
purified as a dimer with an apparent molecular weight of 30
kDa. Simple mixing of the proteins resulted in the forma-
tion of a complex between HipAso and HipBso with an ap-
parent molecular mass of 130 kDa, consistent with 2:2 sto-
ichiometry. Furthermore, the HipABso complex can bind a
single operator DNA sequence to form a complex with a
distinct chromatographic behavior (Figure 1a). Molecular
weights obtained for HipBso, HipBso:DNA HipABso and
HipABso:DNA by SAXS correlate well with the apparent
sizes estimated from the retention volumes in SEC (Supple-
mentary Table S2).
The interaction between HipAso and HipBso, the bind-
ing of HipBso to operator DNA, and the recruitment of
HipAso to the HipBso:DNA complex were quantified us-
ing Isothermal Titration Calorimetry (ITC) (Figure 1b–e).
Two monomers of HipAso bind one dimer of HipBso with
an equilibrium dissociation constant (KD) of 490 nM via an
enthalpically driven binding event (Figure 1b). On the other
hand, the interaction of HipBso with operator DNA (26 bp)
is endothermic, resulting in an entropically driven binding
event to establish a high-affinity interaction (KD = 290 nM)
(Figure 1c). Titration of double operator DNA (76 bp) with
HipBso revealed a similar affinity and thermodynamic fin-
gerprint indicating that there is no cooperativity between
adjacent operators in HipBso binding (Supplementary Ta-
ble S3 and Supplementary Figure S3a). Finally, we charac-
terized the recruitment of HipAso to a HipBso:DNA com-
plex. For this study, we employed preformed HipBso:DNA
complex andHipAso carrying aD306Qmutation and found
that HipAso D306Q can bind to the HipBso:DNA complex
with a KD of 300 nM and a thermodynamic binding pro-
file that is very similar to the HipA:HipB interaction in the
absence of DNA (Figure 1d and Supplementary Table S3).
The rationale behind employing the HipASO D306Q mutant
for these experiments stemmed from the fact that our prepa-
rations of recombinant HipA contained a mixture of non-
phosphorylated and phosphorylated HipA, which we esti-
mated by mass spectrometry to be about 10%. However, we
were neither able to establish protein expression conditions
leading to a stable ratio of non-phosphorylated versus phos-
phorylated HipA, nor a purification protocol that would
allow isolation of the two species for further biochemi-
cal and biophysical characterization. Thus, we resorted to
the HipAD306Q mutant, which is devoid of autophospho-
rylation activity, thereby ensuring the homogeneity of our
preparations with respect to non-phosphorylated HipA.
For comparison purposes and to obtain insights into the
possible binding behavior of phosphorylated HipA, we in-
vestigated the binding of a freshly prepared HipA to a pre-
assembled HipBso:DNA complex by ITC (Figure 1e). Re-
markably, the resultant binding isotherm showed drasti-
cally different features when compared to the binding pro-
file of non-phosphorylated HipAD306Q mutant. The data re-
vealed two distinct binding events and could be fitted with
a ‘two sets of binding sites’ model. A minority of the pool
recombinant HipA molecules consistent with the approxi-
mate proportion of phosphorylated HipA bound with high
affinity to HipB:DNA (KD = 5.5 nM), while a second pool
bound with the expected stoichiometry and a moderately
high affinity (KD = 170 nM).Notably, the latter is consistent
with the affinity of non-phosphorylated HipAD306Q (KD =
300 nM) for the HipB:DNA complex (Figure 1d). Thus, the
two experiments now suggest that phosphorylated HipA
binds with a markedly higher affinity to HipB:DNA than
non-phosphorylated HipA. In addition, this indicates that
the phosphorylation state of HipA bestows high-affinity
binding only when HipB is bound to operator DNA, as ev-
idenced by the fact that the thermodynamic binding profile
for the HipB:HipA interaction (Figure 1b) closely resem-
bles that for the HipB:HipAD306Q complex (Figure 1d). To-
gether, our data point to the possible functional dichotomy
of phosphorylated and non-phosphorylated pools of HipA.
HipAso, HipBso and operator DNA assemble into a distinct
ternary complex
The structure of the HipABso:DNA ternary complex was
determined in two crystal forms at 3.4 A˚ and 3.8 A˚ res-
olution (Table 1). The S. oneidensis MR-1 HipABso:DNA
ternary complex assembles as a compact HipBso dimer
bound by a 25 bp duplex operator DNA, with each of the
HipBso subunits interacting with a separate HipAso sub-
unit (Figure 2a). Unexpectedly, the overall HipABso:DNA
complex assembly is remarkably distinct from the previ-
ously characterized E. coli HipABso:DNA ternary com-
plex (PDB:3DNV) (14) (Figure 2b). Notably, E. coli HipA
uses both its N- and C-terminal domains to contact the
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Figure 1. Biochemical reconstitution and characterization of HipBso (SO0705) and HipAso (SO0706) complexes. (a) SEC profiles of HipBso (orange),
HipAso (blue), HipABso complex (red) and HipABso:DNA complex (green). SDS-PAGE analysis of peak fraction is accompanied with the SEC profile. (b)
Thermodynamic characterization of the interaction between HipAso and HipBso. (c) Thermodynamic characterization of the interaction between HipBso
and single hipBASO operatorDNA. (d) Thermodynamic characterization of the interaction between theHipBso:DNAcomplex and the non-phosphorylated
active site mutant HipAsoD306Q. (e) Thermodynamic characterization of the interaction between the HipBso:DNA complex and recombinant HipAso as
a mixture of phosphorylated (∼10%) and non-phosphorylated HipAso. The derived interaction stoichiometry (N) and equilibrium dissociation constant
(KD) are shown together with H, −TS and G.
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Figure 2. Structural studies of the HipABso:DNA complex. (a) Crystal structure of the HipABso:DNA complex shown in different orientations. A dimer
of HipBso (yellow) interacts with the C-terminal helical bundles (dark blue) of two HipAso; the N-terminus (light blue) of HipAso does not take part in the
interaction with HipBso. (b) X-ray crystal structure of the E.coliHipAB:DNA complex (PDB: 3DNV) in top view oriented based on a superposition with
duplex DNA and HipBso shown in panel (a). (c) SAXS analysis of the HipABso complex and comparison with the crystal structure of HipABso (χ2 = 1.5)
and that ofE. coliHipAB (χ2 = 5.7). (d) Detail of the residues involved in the interaction betweenHipAso andHipBso. (e) Detail of the interaction interface
between HipBso and single hipABso operator DNA. A positively charged patch on HipAso defined by R380, R383, R384 and R429 forms a complementary
interaction site with the negatively charged phosphodiester backbone of the operator DNA. Further interaction details are given in Supplementary Figure
S3b. (f) Bending of the operator DNA upon interaction with the helix-turn-helix motif of HipBso. (g) Structural detail of the interactions stabilizing the
phosphorylated pLoop of HipAso in the ternary complex.
entire side of the HipB dimer, without making any con-
tacts with operator DNA. Thus, viewed from the top of the
DNA double helix, HipAso emerges as a toxin that employs
dramatically different structural principles to engage in a
ternary complex with HipB:DNA compared to the proto-
typic counterpart inE. coli (Figure 2a and b).We have cross-
validated the observed configuration of the HipABso:DNA
complex by SAXS experiments of the complex in solution,
which revealed that the crystallographically observed com-
plex agrees well with the scattering data in solution. At
the same time, a model based on the E. coli HipAB:DNA
complex configuration strongly contradicts our SAXS data
(Figure 2c). Together this analysis lends orthogonal support
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to the crystallographically observed HipABso:DNA com-
plex.
The HipA–HipB binding interface in the HipABso:DNA
ternary complex is mainly hydrophobic and features inter-
actions between the C-terminal helical-bundle domain of
HipA and a hydrophobic patch on eachHipB subunit creat-
ing an interface covering 470 A˚2 as determined by the PDB
PISA server (39) (Figure 2d). Unexpectedly, in addition to
the anticipated extensive interactions of HipB with DNA,
HipA also makes specific interactions with the phospho-
diester flank of the DNA duplex via a positively charged
patch defined by R380, R383 and R384 and R429 covering
an interface of ∼150 A˚2 (Figure 2e). HipB interacts tightly
with its operator DNA using mainly helices 2 and 3 and
part of the 4 helix forming a helix-turn-helix DNA bind-
ing motif (Figure 2f and Supplementary Figure S3b). Inter-
estingly, binding of duplex DNA to the HipABso complex
causes the DNA to bend by about 125◦ compared to linear
DNA, which is 15◦ more than the bent observed in the in-
teraction of E. coli HipB with operator DNA. A possible
reason for this difference may lie in the fact that the inter-
palindromic distance between each operators’ binding site
is 2 bp shorter than in E. coli (Figure 2f).
Arguably the most surprising feature of the
HipABso:DNA complex is the fact that HipAso is phos-
phorylated at Ser147 (Figure 2g). The phosphate group
of pSer147 is observed at full occupancy in both crystal
forms of the HipABso:DNA complex and is anchored by
an anion- interaction with F338. This binding mode is
further stabilized by a hydrogen bond between main-chain
atoms of R145 and F338, and a salt-bridge between
E339 and R145 (Figure 2g). This serendipitous structural
observation, which may well have been the result of protein
crystallization favoring the more stable, albeit much less
abundant, ternary complex of phosphorylated HipAso with
HipBso:DNA (Figure 1e), offers new functional considera-
tions about the possible interplay between phosphorylated
and non-phosphorylated pools of HipAso. Our analysis
by SAXS of recombinant HipABso:DNA in solution
(Figure 2c), which on average may engage up to 10%
phosphorylated HipASO, reveals that the phosphorylated
and non-phosphorylated assemblies are overall structurally
very similar, and further indicates that the structural basis
for the apparent higher affinity of phosphorylated HipAso
for HipBso:DNA will have to await further structural
characterization of non-phosphorylated HipAso complexes
at high resolution.
The flexible C-terminal tail of HipBso becomes ordered upon
binding to HipAso
An additional striking difference between E. coli and S.
oneidensis HipAB:DNA complexes concerns the struc-
tural order of the C-terminal segment of HipB. We posit
that this could have functional implications in terms of
the post-translational regulation. E. coli HipB also dis-
plays structural disorder at its C-terminal end in the
HipAB:DNA complex and it has been demonstrated that
the C-terminal tryptophan is proteolytically cleaved by
the ATP-dependent Lon protease (40). Interestingly, in
our structure of HipABso:DNA at 3.8 A˚ resolution, we
can trace the C terminus of HipBso into a hydrophobic
pocket of HipAso. Moreover, in our second structure of
HipABso:DNA to 3.4 A˚ resolution, we see clear density
in the same pocket for the last three C terminal residues
(Gly95, Trp96 and Tyr97) of HipBso (Figure 3a and Sup-
plementary Figure S3c).
As it is widely accepted that the protease sensitivity of
the antitoxins provides a mechanism for the regulation of
toxin activity (40–42) and given that the C-termimal region
of HipBso is drastically different from its counterpart in E.
coli (Figure 3b), we pursued structural studies of HipBso
outside the context of the ternary complex with HipAso and
DNA to obtain insights into the plasticity and structural
order of the C-terminus in HipBso. We crystallized HipBso
and determined two crystal structures to 1.85 A˚ and 2.35
A˚ resolution, respectively (Table 1 and Figure 3c). The elec-
tron density for the C-terminal segment in HipBso in both
crystal structures did not allow structural modeling, indica-
tive of inherent flexibility in this region in the absence of
a binding partner. To obtain additional structural insights
into this feature of HipBSO, we measured SAXS data for
HipBso alone and HipBso in complex with operator DNA.
Modeling of the SAXS data in both cases using the crys-
tal structure of HipBso and dummy atoms for the miss-
ing C-terminal residues show that, while HipB retains its
compact helical structure, the C-terminus could be mod-
eled as an extended structure protruding outward (Figure
3d). Thus, the C-terminus of HipBso appears to be extended
and flexible in the context of HipBso and its binary complex
with DNA, while it adopts a more defined structure in the
HipABso:DNA complex.
Our modeling of SAXS data for HipBso also provided
the opportunity to validate the structural variability of the
unique N-terminal region of HipBso (Figure 3b), which
adopts two different secondary structures in our structure
of HipBso to 2.35 A˚ resolution, namely a 0 strand in one
subunit and 0′ helix in the other (Figure 3c). We note that
this region could not be modeled in the ternary complex
of HipBso with HipA and DNA due to lack of clear elec-
tron density. In solution, however, the N-terminal segment
of HipBso could only be modeled as an extended structure
analogous to the C-terminal region (Figure 3d). To investi-
gate the possible functional implications of this N-terminal
segment and given that it is completely absent in HipBso
of E. coli, we produced recombinant HipBsolacking the 16
residues atN-terminus and showed by ITC experiments that
its binding behavior to HipAso is indistinguishable from
full-length HipBso (Supplementary Figure S3a).
The conformation of HipAso is modulated by autophosphory-
lation
In E. coli, HipA kinase activity is essential for growth ar-
rest and MDT (12). To further investigate the mechanism
of HipAso in S. oneidensisMR-1, we determined the struc-
ture of HipAso in complex with the non-hydrolysable ATP
analogue AMPPNP and Mg2+ to 1.83 A˚ resolution (Table
1). This structural analysis at high resolution revealed bind-
ing of AMPPNP and Mg2+ at high occupancy and delin-
eation of the protein-nucleotide interaction landscape. The
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Table 1. X-ray data collection and refinement statistics
Crystal
HipAB:DNA crystal
form 1
HipAB:DNA crystal
form 2 HipA:AMPPNP:Mg2+ HipB Dataset 1 HipB Dataset 2
Data collection
Space group P212121 P21 P212121 C2221 C2221
a, b, c (A˚) 57.8, 122.5, 189.9 72.2, 57.3, 171.4 60.7, 75.8, 110.3 53.5, 72.9, 86.9 53.6, 71.6, 85.8
, ,  (◦) 90.0, 90.0, 90.0 90.0, 95.8, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (A˚) 49.4–3.4 (3.5–3.4) 47.6–3.8 (3.9–3.8) 44.6–1.8 (1.9–1.8) 43.1–1.85 (1.95–1.85) 38.36–2.35(2.43–2.35)
Rmeasa 0.260 (1.112) 0.281 (1.051) 0.115 (0.911) 0.074 (0.761) 0.147 (0.935)
CC(1/2) 0.989 (0.673) 0.983 (0.538) 0.999 (0.904) 0.998 (0.742) 0.995 (0.744)
I/(I) 6.78 (1.81) 4.40 (1.21) 19.96 (3.17) 11.66 (1.68) 11.21 (2.15)
Completeness (%) 98.93 (92.72) 97.03 (84.10) 99.43 (95.29) 99.46 (99.20) 99.71 (97.55)
Multiplicity 6.5 (6.4) 3.4 (2.9) 13.1 (12.5) 4.5 (4.4) 6.3 (6.3)
Wilson B-factor (A˚2) 75.5 93.1 21.3 31.0 40.1
Refinement
Total reflections 124924 (11122) 46748 (3379) 592535 (53603) 67170 (6306) 45147 (4242)
Unique reflections 19211 (1732) 13858 (1164) 45100 (4273) 14778 (1440) 7125 (676)
Rwork/Rfree 0.256/0.315 0.236/0.306 0.156/0.175 0.186/0.216 0.204/0.223
Number of atoms:
Protein 8805 8763 3466 1019 1070
Ligand or ion - - 34
Water 486 123 39
Average ADP (A˚2) 46.4 80.3 27.2 33.9 49.2
Protein ADP (A˚2) 46.4 80.3 26.4 33.2 49.2
Ligand ADP (A˚2) - - 11.6
Water ADP (A˚2) 33.8 39.5 47.6
Ramachandran Plot
Favored/Allowed (%) 98/2 97/3 98/2 99/1 99/1
Root-mean-square
deviations:
Bond lengths (A˚) 0.003 0.005 0.005 0.004 0.004
Bond angles (◦) 0.80 0.95 0.95 0.68 0.88
aRmeas =
∑
h
√
nh/(nh−1)
∑
h
∑
i |I(h,i)−I(h)>| /
∑
h
∑
iI(h,i), where nh is the multiplicity, I(h,i) is the intensity of the ith measurement of reflection h, and
I(h)> is the average value over multiple measurements. Statistics for the highest resolution shell are shown in parentheses.
ATP binding site in HipAso is engulfed by the N- and C-
terminal domains and most interacting residues are con-
tributed by five loop regions (Figure 4a and Supplementary
Figure S4a). All residues involved inMg2+ andATPbinding
are highly conserved in S. oneidensisMR-1 and E. coli (Fig-
ure 4a and Supplementary Figure S1). Given that the physi-
ological ATP concentration in the cell is enough to drive the
autophosphorylation of HipA, we propose that phosphory-
lation of HipAso is essential for the formation of the ternary
HipABso:DNA complex. The HipAso pLoop consists of
residues 129–152 and is ejected out of the pocket compared
to the non-phosphorylated form (Figure 4b). Furthermore,
the pLoop in autophosphorylated HipAso, as observed in
the HipABso:DNA complex, projects to the surface. Such
activationmechanism involving ejection of the pLoop upon
phosphorylation has also been proposed for E. coli HipA
(43). This could be a common feature for the HipA kinase
family. To investigate the autophosphorylation capacity of
HipAso, we incubated freshly purifiedHipAso withATP and
Mg2+ overnight and observed a dramatic increase of the
corresponding phosphorylated peptide intensity from ap-
proximately 5% to almost 45% relative to the signal of the
non-phosphorylated peptide in LCMS (Figure 4c).
In E. coli, HipAso is autophosphorylated at Ser150. Sim-
ilarly, our structural analysis revealed that in S. oneiden-
sis MR-1, HipA can be autophosphorylated at Ser147
which aligns with Ser150 in E. coli HipA. We note that
both our crystal forms of the HipABso:DNA complex con-
tain phosphorylated HipA, in sharp contrast to the E.
coli HipAB:DNA complex (43,44). Upon superposition
of the N-terminal domains of phosphorylated and non-
phosphorylated HipAso (derived from the AMPPNP com-
plex) we observed a rigid-body shift of the HipAso C-
terminal domain by about 2 A˚ (Supplementary Figure S4c).
Given that this part of HipAso interacts with DNA in the
ternary complexwithHipBso, we propose that the phospho-
rylated form of HipAso may be important in the complex
assembly and stability.
HipAso neither binds nor phosphorylates EF-Tuso
HipA was the first toxin protein to be linked to the phe-
nomenon of persistence and its overexpression in E. coli
resulted in growth arrest, inhibition of protein synthesis,
as well as DNA replication and transcription (7,15,12,37).
These multiple cellular effects at the molecular level could
be traced to the kinase activity of HipA (12). EF-Tu was
originally identified as the substrate of the kinase activity of
HipA in E. coli, thereby creating a functional link between
HipA and the inhibition of translation (14). However, re-
peated attempts to show that HipAso has an analogous ac-
tivity failed, leading to the conclusion that EF-Tuso does
most likely not constitute a substrate for HipAso (Supple-
mentary Figure S5a). In an in vitro radioactive kinase assay,
we could show that HipAso is indeed autophosphorylated,
while the active site mutant HipAso D306Q is not. However,
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Figure 3. The flexible C-terminal tail of HipBso is accommodated by a hydrophobic pocket in HipAso. (a) Structural detail of the interaction site between
HipBso (yellow) and HipAso (blue). (b) Structure-based sequence alignment of S. oneidensis and E. coli HipB (18% identity) showing the conserved W96
residue. (c) Crystal structure (2.35 A) of the HipBso dimer showing the different conformations of the N-termini forming a 0′ helix and 0 sheet, respec-
tively. (d) SAXS modeling showing both HipBso and HipBso:DNA complex have a disordered N- and C-terminus. Five CORAL models, aligned with the
N- and C-termini, are colored differently and shown in sphere representation.
no phosphorylation of EF-Tuso could be detected when pu-
rified EF-Tuso with C-terminal His-tag or N-terminal glu-
tathione S-transferase (GST) tag was added. Furthermore,
ITC and pull-down experiments with GST-tagged EF-Tuso
indicated the absence of interaction between these proteins
thereby corroborating the functional assay (Supplementary
Figure S5b).
DISCUSSION
We here provide structural insights into the toxin–antitoxin
system HipA-HipB and its operator DNA assembly in S.
oneidensis MR-1, which can now serve as a second exam-
ple of such complexes next to the previously character-
ized E. coli HipAB:DNA complex. The S. oneidensis MR-
1 HipAB:DNA assembly is sharply distinct from the one
in E. coli, providing new insights into the structural and
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Figure 4. S. oneidensisMR-1 HipAso is regulated conformationally upon autophosphorylation. (a) Structural detail of the AMPPMP (atom colored) and
Mg2+ (green spheres) binding site in HipAso (blue). Residues involved are shown in stick representation. (b) Detailed view of the ejection of the pLoop
of HipAso upon autophosphorylation. Ser147 and phosphate represented as spheres. (c) Identification of the phosphorylated peptide by nanoLCMS. The
peptide LSVAGVQPK was observed at charge state 2+ in two forms differing by 80 Da in molecular weight. Sequence alignment of the pLoop regions in
S. oneidensisMR-1 and E. coli.
mechanistic diversity of HipAB modules and cautioning
against the use of a single model organism for deriving
functional generalizations. In E. coli, the phosphorylation
of HipA evokes pLoop ejection and is thought to release
HipA from HipB in the HipAB:DNA complex (43). How-
ever, we have now provided direct structural and biophys-
ical evidence that phosphorylated HipASO can engage in
the HipABso:DNA complex form with higher affinity that
non-phosphorylated HipASO, and further, that the phos-
phorylation site is secured in place via anion– interac-
tions. This suggests that HipB may play an active role in
recruiting phosphorylated HipA to avoid growth arrest. We
also observed that in the absence of HipA, HipB is struc-
turally destabilized, which may render HipB more suscepti-
ble to proteolytic degradation, thereby propagating the ef-
fect of HipA-regulated persistence. This raises new ques-
tions about the possible molecular trigger for the release of
HipA fromHipB given the observation that pLoop ejection
does not appear to do so.
Understanding MDT and persistence in bacteria is crit-
ical for the development of eradication strategies against
persisters, and may thus impact therapeutic options for
chronic infections. Besides HipBA systems, several other
molecular factors have been shown to contribute to bacte-
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rial persistence (45,46), and it has been proposed that the
level of toxin controls the formation of persister subpopula-
tions in a threshold-basedmanner (47). In fact, TAmodules
are tightly regulated based on a complex molecular inter-
play (48). In particular, a number of type II TA systems ex-
hibit ‘conditional cooperativity’, a term coined to describe
the transcriptional repression of the TA system depending
on the ratio of toxin to antitoxin (49–51). For instance, con-
ditional cooperativity was reported to stabilize antitoxin
levels in rapidly growing cells, preventing the random ac-
tivation of toxin and promoting fast translational recovery
(52), and in Doc-Phd or RelA-RelB toxin-antitoxin systems
it is essential for keeping a storage pool of the toxin to gener-
ate type I persistence (49,53). However, thus far conditional
cooperativity has not been demonstrated for the HipAB
module in persister cell formation. Furthermore, the sim-
ple threshold-based models are still far from satisfactory
because they ignore key aspects of the HipAB autoregula-
tion pathway, such as autophosphorylation of HipA and its
possible effects on reverting growth arrest (47,54). In this
regard, we envisage that the identification of the effective
population of HipA involved in HipB binding will be key
to further understand bacterial persistence and to develop
bistability models (49,53). Furthermore, it will be crucial
to verify the conformational state of HipA involved in the
ternary complex with HipB and operator DNA leading to
transcriptional suppression. In particular, the involvement
of phosphorylatedHipA in theHipAB:DNA complex hints
that by characterizing the equilibrium between the differ-
ent conformational states of HipA in a cellular context one
may be able to rationalize storage of HipA along the lines
of the conditional cooperativity mechanism proposed for
other type II toxin–antitoxin systems.
We have further shown that EF-Tu is unlikely to be the
substrate of toxin HipA in the case of S. oneidensis, which
is in agreement with recent findings in E. coli. While it was
originally believed that HipA halted ribosomal activity by
phosphorylating EF-Tu (14,43), it was recently established
that its natural substrate is actually GltX. By phosphorylat-
ing this enzyme at its ATP binding site, uncharged tRNAGlu
accumulates, leading to the activation of the stringent re-
sponse. This induces degradation of the antitoxins by Lon
protease, which finally leads to conversion of the cell to
the persister state (13,55). However, translational inhibition
alone is not sufficient to explain the macromolecular syn-
thesis inhibition triggered by HipA (16).
Mining the S. oneidensis MR-1 genome database and
the Toxin-Antitoxin database (TADB) revealed that multi-
ple homologues of the HipAB toxin–antitoxin system exist
in S. oneidensis MR-1 (56). Besides SO0705 (HipBso) and
SO0706 (HipAso), SO3169, SO3170 and SO0062, SO0063
are also annotated as members of the HipAB toxin–
antitoxin system. Interestingly, despite the low sequence
identity (15–20%) between the predicted HipA-like pro-
teins SO3170, SO0063 and SO0706, the residues involved
in HipA kinase activation, in terms ofMg2+ and ATP bind-
ing and the Ser phosphorylation site, are highly conserved
(Supplementary Figure S6). Although there is only a low
sequence identity between E. coli and S. oneidensis HipA,
their structure is highly similar and they share a kinase
activation mechanism characterized by a conformational
change of the pLoop. Moreover, upstream of the gene en-
coding for one of these HipA homologues there is a gene
encoding for aHipB-like protein. Thus, it appears that there
might be functional redundancy of such proteins in S. onei-
densis, which may complicate future studies in delineating
the exact role of HipA in this organism.
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